Key Insights

Highlights

Success Rate

84% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

3.8%

3 terminated out of 78 trials

Success Rate

84.2%

-2.3% vs benchmark

Late-Stage Pipeline

6%

5 trials in Phase 3/4

Results Transparency

13%

2 of 16 completed with results

Key Signals

2 with results84% success

Data Visualizations

Phase Distribution

63Total
Not Applicable (46)
Early P 1 (1)
P 1 (2)
P 2 (9)
P 3 (3)
P 4 (2)

Trial Status

Recruiting23
Unknown22
Completed16
Not Yet Recruiting7
Withdrawn5
Terminated3

Trial Success Rate

84.2%

Benchmark: 86.5%

Based on 16 completed trials

Clinical Trials (78)

Showing 20 of 20 trials
NCT07740239Recruiting

A COhort Study on Factors Leading to Vulnerability in Adult Patients With Serious Medical cOnditionS: the COSMOS-I Trial

NCT07197840RecruitingPrimary

The CHALLENGER Registry

NCT07731620Not ApplicableNot Yet RecruitingPrimary

Frontal vs Parietal Eminence Drainage for Chronic Subdural Hematoma

NCT07729098Phase 1Not Yet RecruitingPrimary

Intra-Arterial Bevacizumab as an Adjunct to Middle Meningeal Artery Embolization for Chronic Subdural Hematoma

NCT07720687Not ApplicableNot Yet RecruitingPrimary

Template-Guided Burr-Hole Drainage With Middle Meningeal Artery Coagulation for Chronic Subdural Hematoma

NCT07715656Not ApplicableRecruitingPrimary

Assessing Outcomes of Coil Embolization for Unilateral vs Bilateral Chronic Subdural Hematomas

NCT07245264Phase 2RecruitingPrimary

Adjuvant Tranexamic Acid (TXA) Versus Surgery Alone for Adult Patients With Chronic Subdural Hematoma (CSDH)

NCT06772740Not ApplicableRecruiting

Middle Meningeal Artery Embolization for Patients With Chronic Subdural Hematoma

NCT07688473Not ApplicableActive Not RecruitingPrimary

Surgical Management of Chronic Subdural Hematoma: Clinical Outcomes Following Single VS Double Burr Holes Evacuation

NCT04816591Not ApplicableCompletedPrimary

Middle Meningeal Artery Embolization for the Treatment of Subdural Hematomas With TRUFILL® n-BCA

NCT05374681Not ApplicableRecruitingPrimary

Efficacy of a Minimally Invasive Therapy Adjuvant to the Standards of Care by Cyanoacrylate Embolization

NCT07656818Not ApplicableRecruitingPrimary

Non-Thermal Plasma to Reduce Recurrence in Chronic Subdural Hematoma

NCT06347796Not ApplicableRecruitingPrimary

Chronic Subdural Hematoma Treatment With Embolization Versus Surgery Study

NCT06401772Not ApplicableRecruitingPrimary

The Effectiveness and Safety of Body Posture in Preventing Postoperative Recurrence for Chronic Subdural Hematoma

NCT04750200Not ApplicableActive Not RecruitingPrimary

Management of CSDH With or Without EMMA- a Randomized Control Trial

NCT04966546Early Phase 1WithdrawnPrimary

Targeting Spreading Depolarization After Chronic Subdural Hematoma Surgery (TASD)

NCT07421453RecruitingPrimary

Implementation of an Enhanced Recovery Pathway for Burr-hole Drainage in Patients With a Chronic Subdural Hematoma

NCT07144423Not ApplicableRecruitingPrimary

Neuroendoscopy-assisted Drainage Versus Burr Hole Drainage for Chronic Subdural Hematoma

NCT07368101Not ApplicableCompletedPrimary

Outcome of Chronic Subdural Hematoma Management With Double Burr Hole Craniotomy Versus Single Burr Hole Craniotomy and Subdural Drain Evacuation

NCT06181994RecruitingPrimary

Middle Meningeal Artery Embolization (MMAE) Outcomes for Chronic Subdural Hematoma (cSDH)

Scroll to load more

Research Network

Activity Timeline